Cargando…
Nasal Vaccine Delivery
The mucosal surfaces represent the major site of entry of many pathogens, and major challenges in vaccine development include safety and stability in a suitable dosage form. Micro- and nanocarrier-based delivery systems as nasal vaccines induce humoral, cellular, and mucosal immunity. The nasal rout...
Autores principales: | Ramvikas, M., Arumugam, M., Chakrabarti, S.R., Jaganathan, K.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151830/ http://dx.doi.org/10.1016/B978-0-323-39981-4.00015-4 |
Ejemplares similares
-
Nanotechnologies in Delivery of DNA and mRNA Vaccines to the Nasal and Pulmonary Mucosa
por: Tang, Jie, et al.
Publicado: (2022) -
Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model mice
por: Takeuchi, Hiroki, et al.
Publicado: (2020) -
Chrysanthemum sporopollenin: A novel vaccine delivery system for nasal mucosal immunity
por: Liu, Jun, et al.
Publicado: (2023) -
Nasal Delivery of Acute Medications for Migraine: The Upper Versus Lower Nasal Space
por: Martin, Vincent, et al.
Publicado: (2021) -
C-Terminal Clostridium perfringens Enterotoxin-Mediated Antigen Delivery for Nasal Pneumococcal Vaccine
por: Suzuki, Hidehiko, et al.
Publicado: (2015)